Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Derma Sciences signs multi-year supply agreement with MedAssets for Medihoney dressings

Derma Sciences : 24 April, 2008  (Company News)
Derma Sciences has signed a new multi-year supply agreement with one of the USA's largest group purchasing organizations, MedAssets Supply Chain Systems, a MedAssets company.
The three-year agreement, with an effective date of June 1, 2008, will help to introduce Medihoney Wound and Burn Dressing with Active Leptospermum Honey to the organization's growing customer base, and will provide these customers with a group discounted rate. Currently, MedAssets serves more than 125 health systems, 2,500 hospitals and 30,000 non-acute care healthcare providers. On an annual basis, MedAssets manages on behalf of its customers, an excess of $15 billion in supplies and services.

This supply agreement for specialty advanced wound care products features Derma Sciences' MEDIHONEY, line of dressings with Active Leptospermum Honey for managing a wide variety of wounds and burns. In July, the FDA gave its initial clearance of MEDIHONEY, and the product was launched last fall. Since then, another clearance for a line extension has been granted and a third is pending. Sales have rapidly increased, and over 20 clinical abstracts on the use of the product have been accepted at various wound conferences in 2008.

Marta V Beile RN, a director of clinical supply chain for MedAssets' materials management division, decided it would be highly beneficial for MedAssets customers to carve out a ‘specialty’ products agreement for this exciting new product. Beile stated, 'It makes sense to provide our wound care clinicians with additional options to help heal patients. Medihoney appears to offer incremental clinical benefits that may better enable our customers to provide optimal wound care.'

Speaking of the new agreement, Derma Sciences' chief executive officer Ed Quilty stated, 'This is an important milestone for us. Group purchasing agreements such as this one will open up vast new selling opportunities for our growing sales team. MedAssets is a prominent group purchasing organization and we are pleased they decided to enter into an agreement with Derma for our proprietary product. We look forward to educating their customers on the benefits of Medihoney.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 ProHealthServiceZone.com
Netgains Logo